LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Search

Illumina Inc

Cerrado

Sector Salud

129.19 2.41

Resumen

Variación precio

24h

Actual

Mínimo

128.89

Máximo

129.6

Métricas clave

By Trading Economics

Ingresos

-1.9B

-2B

Ventas

30M

1.1B

BPA

0.36

Margen de beneficio

-179.099

Empleados

10,590

EBITDA

-1.9B

-1.9B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+15.39 upside

Dividendos

By Dow Jones

Próximas Ganancias

7 nov 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

21B

Apertura anterior

126.78

Cierre anterior

129.19

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

338 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Illumina Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

11 dic 2023, 18:43 UTC

Adquisiciones, fusiones, absorciones

Illumina Submits SEC Form For Grail Divestiture

13 oct 2023, 18:42 UTC

Adquisiciones, fusiones, absorciones

Illumina Gets European Commission Order to Divest Grail

5 mar 2024, 08:00 UTC

Ganancias

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18 dic 2023, 23:17 UTC

Adquisiciones, fusiones, absorciones

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18 dic 2023, 20:33 UTC

Adquisiciones, fusiones, absorciones

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18 dic 2023, 09:48 UTC

Adquisiciones, fusiones, absorciones

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18 dic 2023, 09:34 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9 nov 2023, 09:39 UTC

Ganancias

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Illumina Inc Esperado

Precio Objetivo

By TipRanks

15.39% repunte

Estimación a 12 meses

Media 149.06 USD  15.39%

Máximo 242 USD

Mínimo 105 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Illumina Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

18 ratings

11

Comprar

6

Mantener

1

Vender

Puntuación técnica

By Trading Central

126.25 / 130.7545Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

338 / 365 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.